OnCusp Therapeutics logo

OnCusp Therapeutics

We Bring Oncology Innovation to Life

28 employees · est. 2021 · New York, United States

VS
Shorla Oncology logo

Shorla Oncology

At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers.

38 employees · est. 2018 · Ireland

Shorla Oncology is the older company (2021 vs 2018).

Side-by-Side Comparison

OnCusp Therapeutics Shorla Oncology
Founded
2021 2018 older
Headquarters
New York, United States Ireland
Employees
28 38
Industry
Biotechnology, Health Care, Pharmaceutical Health Care, Manufacturing, Pharmaceutical
Funding Stage
Series A Series B
Total Funding
$125.00M $43.30M
Funding Rounds
2 2
Services
Development of Oncology Treatments, Clinical R&D, Partnership and Collaboration, Business Development Not tracked yet
Target Customers
Cancer Patients, Healthcare Providers, Pharmaceutical Companies, Research Institutions Not tracked yet
Taxonomy
Biopharmaceutical, Oncology, Cancer Treatments, Preclinical Innovation, Clinical Validation, Drug Development, Biotech Startups, Global Partnerships, Oncology Assets, Innovation Acceleration, Research Asset Transformation, Oncology Medication Innovation Oncology Drugs, Cancer Treatments, Women's Health, Pediatric Oncology, Drug Development, Commercialization, Unmet Medical Needs, Clinical Impact, Innovation, Life-saving Treatments
Website
oncusptx.com shorlaoncology.com
OnCusp Therapeutics logo

About OnCusp Therapeutics

OnCusp Therapeutics is a promising player in the biopharmaceutical industry, founded in 2021 with headquarters in the United States. Their mission, elegantly encapsulated in their slogan, "We Bring Oncology Innovation to Life," reflects a dedication to evolving preclinical discoveries into validated...

Shorla Oncology logo

About Shorla Oncology

Shorla Oncology is an Irish healthcare startup that focuses on the development and commercialization of innovative oncology drugs, particularly targeting women's and pediatric cancers. Founded in 2018, the company's mission is to address the gaps in existing cancer treatments by providing accessible...

We will tell you when either one moves

BounceWatch watches OnCusp Therapeutics and Shorla Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at OnCusp Therapeutics and Shorla Oncology — by email.

Frequently Asked Questions

OnCusp Therapeutics — We Bring Oncology Innovation to Life. Shorla Oncology — At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
OnCusp Therapeutics has raised $125.00M while Shorla Oncology has raised $43.30M.
OnCusp Therapeutics and Shorla Oncology operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare OnCusp Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at OnCusp Therapeutics on 9 Jun 2026, and Shorla Oncology on 25 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy